Literature DB >> 29030775

Improvement in pregnancy outcomes in couples with immunologically male infertility undergoing prednisolone treatment and conventional in vitro fertilization preceded by sperm penetration assay: a randomized controlled trial.

Ahmed M Taiyeb1, Mundhir T Ridha-Albarzanchi2,3, Shereen M Taiyeb2, Zuhair A Kanan2,3, Shahla K Alatrakchi2, Michael E Kjelland2,4, Saeeda A Muhsen-Alanssari2,3.   

Abstract

PURPOSE: Anti-sperm antibodies (ASA) in men impair not only sperm motility but also fertilization and conception. However, utilization of corticosteroids to suppress ASA has shown variable pregnancy outcomes. This controversy is also extended to include the usefulness of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in treatments of men with ASA. This study was therefore designed to define factors contributing to these inconsistent results.
METHODS: Infertile men having ASA (n = 241) were randomly assigned for treatment with or without prednisolone for three cycles each of 21 days of their partner's menstrual cycles. Control and treated men underwent then human sperm penetration assay (SPA), of hamster oocytes, to diagnose men with impaired sperm fusogenic capacity. Men with positive or negative SPA results were admitted to conventional IVF or ICSI programs, respectively.
RESULTS: Treated patients had improved sperm motility and progressive motility when compared to control patients (P < 0.001). Fertilization (P = 0.04), embryo cleavage (P = 0.01), and chemical (P = 0.02) and clinical (P = 0.04) pregnancy rates were higher in treated patients than in control patients undergoing conventional IVF but not ICSI cycles.
CONCLUSIONS: Men with ASA may also have compromised sperm fusogenic capacity, which can mask the clinical significance of corticosteroids. Corticosteroid administration in men with ASA, but without compromised sperm fusogenic capacity, improves conventional IVF but not ICSI outcomes; the reason being that ICSI bypasses issues of compromised fusogenic capacity. Inclusion of SPA in infertility clinics that offer both conventional IVF and ICSI services may be useful to identify which patients with ASA benefit from corticosteroid treatments.

Entities:  

Keywords:  Anti-sperm antibodies; In vitro fertilization; Intracytoplasmic sperm injection; Prednisolone; Sperm penetration assay

Mesh:

Substances:

Year:  2017        PMID: 29030775     DOI: 10.1007/s12020-017-1446-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

1.  Sperm hyperactivation as quality control for sperm penetration assay.

Authors:  P J Chan; D R Tredway; B C Su; J Corselli; B J Davidson; M Sakugawa
Journal:  Urology       Date:  1992-01       Impact factor: 2.649

Review 2.  Antisperm antibodies are not associated with pregnancy rates after IVF and ICSI: systematic review and meta-analysis.

Authors:  Armand Zini; Nader Fahmy; Eric Belzile; Antonio Ciampi; Naif Al-Hathal; Ahmed Kotb
Journal:  Hum Reprod       Date:  2011-03-23       Impact factor: 6.918

Review 3.  Sperm immunology, infertility, and fertility control.

Authors:  T S Li
Journal:  Obstet Gynecol       Date:  1974-10       Impact factor: 7.661

4.  Conception rates in couples where autoimmunity to sperm is detected.

Authors:  B Ayvaliotis; R Bronson; D Rosenfeld; G Cooper
Journal:  Fertil Steril       Date:  1985-05       Impact factor: 7.329

5.  Treatment of severe male immunological infertility by intracytoplasmic sperm injection.

Authors:  A Lähteenmäki; I Reima; O Hovatta
Journal:  Hum Reprod       Date:  1995-11       Impact factor: 6.918

Review 6.  Male infertility testing: reactive oxygen species and antioxidant capacity.

Authors:  Edmund Y Ko; Edmund S Sabanegh; Ashok Agarwal
Journal:  Fertil Steril       Date:  2014-11-25       Impact factor: 7.329

7.  Influence of incubation time/temperature on acrosome reaction/sperm penetration assay.

Authors:  R Sanchez; W B Schill
Journal:  Arch Androl       Date:  1991 Jul-Aug

8.  Sperm-specific isoantibodies and autoantibodies inhibit the binding of human sperm to the human zona pellucida.

Authors:  R A Bronson; G W Cooper; D L Rosenfeld
Journal:  Fertil Steril       Date:  1982-12       Impact factor: 7.329

9.  Evaluation of human sperm hyperactivated motility and its relationship with the zona-free hamster oocyte sperm penetration assay.

Authors:  C Wang; A Leung; W L Tsoi; J Leung; V Ng; K F Lee; S Y Chan
Journal:  J Androl       Date:  1991 Jul-Aug

10.  Effect of low-dose prednisolone on sperm fertilizing capacity in subfertile men with circulating antisperm antibodies.

Authors:  P Curtis; S Preutthipan; K Gleeson; R W Shaw
Journal:  Arch Androl       Date:  1994 Sep-Oct
View more
  4 in total

Review 1.  Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.

Authors:  Carolien M Boomsma; Mohan S Kamath; Stephen D Keay; Nick S Macklon
Journal:  Cochrane Database Syst Rev       Date:  2022-06-30

Review 2.  Antisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical Practices.

Authors:  Sajal Gupta; Rakesh Sharma; Ashok Agarwal; Florence Boitrelle; Renata Finelli; Ala'a Farkouh; Ramadan Saleh; Taha Abo-Almagd Abdel-Meguid; Murat Gül; Birute Zilaitiene; Edmund Ko; Amarnath Rambhatla; Armand Zini; Kristian Leisegang; Shinnosuke Kuroda; Ralf Henkel; Rossella Cannarella; Ayad Palani; Chak-Lam Cho; Christopher C K Ho; Daniel Suslik Zylbersztejn; Edoardo Pescatori; Eric Chung; Fotios Dimitriadis; Germar-Michael Pinggera; Gian Maria Busetto; Giancarlo Balercia; Gianmaria Salvio; Giovanni M Colpi; Gökhan Çeker; Hisanori Taniguchi; Hussein Kandil; Hyun Jun Park; Israel Maldonado Rosas; Jean de la Rosette; Joao Paulo Greco Cardoso; Jonathan Ramsay; Juan Alvarez; Juan Manuel Corral Molina; Kareim Khalafalla; Kasonde Bowa; Kelton Tremellen; Evangelini Evgeni; Lucia Rocco; Marcelo Gabriel Rodriguez Peña; Marjan Sabbaghian; Marlon Martinez; Mohamed Arafa; Mohamed S Al-Marhoon; Nicholas Tadros; Nicolas Garrido; Osvaldo Rajmil; Pallav Sengupta; Paraskevi Vogiatzi; Parviz Kavoussi; Ponco Birowo; Raghavender Kosgi; Saleem Bani-Hani; Sava Micic; Sijo Parekattil; Sunil Jindal; Tan V Le; Taymour Mostafa; Tuncay Toprak; Yoshiharu Morimoto; Vineet Malhotra; Azin Aghamajidi; Damayanthi Durairajanayagam; Rupin Shah
Journal:  World J Mens Health       Date:  2022-01-01       Impact factor: 6.494

3.  Practical Clinical and Diagnostic Pathway for the Investigation of the Infertile Couple.

Authors:  Andrea Garolla; Damiano Pizzol; Andrea Roberto Carosso; Andrea Borini; Filippo Maria Ubaldi; Aldo Eugenio Calogero; Alberto Ferlin; Antonio Lanzone; Francesco Tomei; Bruno Engl; Laura Rienzi; Lucia De Santis; Giovanni Coticchio; Lee Smith; Rossella Cannarella; Attilio Anastasi; Massimo Menegazzo; Liborio Stuppia; Christian Corsini; Carlo Foresta
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

Review 4.  Outcome reporting across randomized controlled trials evaluating potential treatments for male infertility: a systematic review.

Authors:  Michael P Rimmer; Ruth A Howie; Venkatesh Subramanian; Richard A Anderson; Ricardo Pimenta Bertolla; Yusuf Beebeejaun; Pietro Bortoletto; Sesh K Sunkara; Rod T Mitchell; Allan Pacey; Madelon van Wely; Cindy M Farquhar; James M N Duffy; Craig Niederberger
Journal:  Hum Reprod Open       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.